Alan HunterExecutive Director at AstraZenecaSpeaker
Alan K. Hunter holds a Ph.D. in Chemical Engineering from the University of Virginia, where as a graduate student he studied process chromatography and protein mass transport. He has worked in the biopharmaceutical industry for over 20 years, beginning with roles at Cambrex and Pfizer Global Biologics. In 2009, he moved to AstraZeneca where he is currently employed as an Executive Director in the Purification Process Sciences group. At AstraZeneca, he leads a team responsible for developing purification processes for cGMP manufacture novel biotherapeutics. He has extensive experience with CMC team leadership, regulatory filings, and strategy for early and late-stage drug development.